#ISHLT recently awarded the Acellular #EVLP Perfusion #ResearchGrant, supported by #LungBioengineering, to Laurens Ceulemans of KU Leuven. 🎉 His study examines CRISPR-Cas9 gene-editing, a molecular "scissor" that precisely targets & disrupts specific genes. 🫁

Learn more at 🔗 bit.ly/4qCGObN

The second slide of December 2025's ISHLT Journal Watch, reviewing the study "Cell-free DNA in Ex-Vivo Lung Perfusate is Associated With Low-Quality Lungs and Lung Transplant Outcome." A more screenreader friendly version of the issue can be found at https://www.ishlt.org/docs/default-source/journal-watch/202512_journalwatch_pulm_dec2025.pdf

Next in #ISHLTJournalWatch, Alex Dragnich reviews a study from @jhlt.bsky.social—can #cellfreeDNA in #EVLP perfusate reflect #lung quality and affect the decision to use in #transplantation?

@sirusjj.bsky.social

ISHLT Early Career-Led Literature Review in Pulmonology The December 2025 issue of ISHLT's Journal Watch explores topics in pulmonology, advanced lung failure, and transplant.

The December #ISHLTJournalWatch highlights pulmonology research, edited by @sirusjj.bsky.social.

Topics include gliptins and #CLAD, #cfDNA in #EVLP perfusate, lung allocation strategy, and #connectivetissue diseases in #lungtx.

#ISHLT #pulmsky #transplantsky

www.ishlt.org/about/news-d...

This is tomorrow! Will we see you there for a discussion on how #EVLP approaches differ around the world?

#PulmSky #TransplantSky #Perfusion #Allograft

This #LungBioengineering #EVLP webinar is next week! 📅 Mark your calendars for an hour long discussion on differing global approaches to #Lung #Perfusion and #allograft selection.

#PulmSky #TransplantSky

bit.ly/4jnHMo1

Industry Webinar: Ex Vivo Lung Perfusion Consensus: European and American Perspectives This webinar will explore the differences between the European and American approaches on selecting allografts for EVLP and the implications for resource utilization and clinical outcomes.

On 17 June, a free one-hour webinar from Lung Bioengineering will host experts from Europe & USA to discuss pivotal ex vivo lung #perfusion consensus documents and different approaches on selecting allografts for #EVLP, plus implications for clinical outcomes.

#PulmSky #TransplantSky

So many tools 🛠️ to optimize donor lungs 🫁 as we use them for our transplant ♻️ candidates. Intrigued how different techniques, technologies, and donor selection may give our patients the best chance at success. 👌 moderation by Dr. Benden (Boston Children's) at #ISHLT2025! #LungTransplant #EVLP

Ideal preservation ❄️ of lungs 🫁 is critical for successful lung txp ♻️. Excited to hear how 🫁 perform across different ❄️ strategies and EVLP 🤖📦. Appreciate the stellar moderation by Dr. Cantu (UPenn) and Dr. Schwarz (Vienna) at #ISHLT2025! #LungTransplant #EVLP

Thank you Kenneth McCurry and your fantastic team, Toshihiro Okamoto Kamal Ayyat for a great couple of days with excellent presentations and discussions about #EVLP and lung transplant.
Cleveland Clinic
XVIVO

I would like to thank all speakers, but the post would be too long

See you all soon

Thank you Kenneth McCurry and your fantastic team, Toshihiro Okamoto @Kamal Ayyat for a great couple of days with excellent presentations and discussions about #EVLP and lung transplant.
Cleveland Clinic
XVIVO

I would like to thank all speakers, but the post would be too long

See you all soon

Drug delivery system offers hope for treating genetic dis... A team of researchers has developed a new drug delivery s...

Drug delivery system offers hope for treating genetic diseases - Researchers able to edit genes linked to high cholesterol and partially restore vision in mice news.harvard.edu/gazette/story/2022/02/dr... #eVLP